RxDoctor Payments Data

Frederick Reindel, MD

Psychiatry · Bristol, CTNPI 1134117492

Payments from drug & device makers

$2,143in general payments, 2019–2025

Across 113 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$321
  • AbbVie$284
  • Johnson & Johnson$274
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$190
  • Neurocrine Biosciences, Inc.$178
  • Takeda Pharmaceuticals U.S.A., Inc.$160
  • plus $737 from 13 others

What the payments were for

  • Food & beverage$2,143100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,143 in reported general payments places this provider in the 80th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$14,966
Medicare patients
57
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole43$78,628
TrintellixVortioxetine Hydrobromide13$24,648
Seroquel XrQuetiapine Fumarate12$8,922
Aripiprazole25$3,078
Adderall XrDextroamphetamine/Amphetamine13$2,830
Bupropion XlBupropion Hcl121$2,773
Clonazepam244$2,324
Venlafaxine Hcl ErVenlafaxine Hcl74$1,798
Alprazolam208$1,454
Mirtazapine79$1,415
Escitalopram Oxalate123$1,355
Clozapine23$1,349
Duloxetine Hcl87$1,311
Divalproex Sodium ErDivalproex Sodium29$1,139
Quetiapine Fumarate78$1,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$68$78,62843 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$160$24,64813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 644 psychiatry providers in Connecticut.

Other psychiatry in Bristol

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →